obesity drug news today glp-1 october 2025 therapies are changing care. What does WHO recommend? , Here’s what you need to know GLP-1 Drugs: 2025 Pulse Survey

Poor penetration of drugs into fungal biofilms leading to persistent and recurrent infections (Zhang et al., 2023)

Abaza M-S, Al-Attiyah R, Bhardwaj R, Abbadi G, Koyippally M, Afzal M

The answer depends on what "better" means for your specific goals, your metabolic profile, and how you weigh factors like availability, safety data, and long-term track record

GLP-1 medications offer notable sleep improvements for individuals struggling with this condition

NAD+ Metabolism and the Control of Energy Homeostasis: A Balancing Act between Mitochondria and the Nucleus

Chemical peels and laser treatments can be effective but may come with significant downtime and potential side effects